| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 10,135 | 10,784 | ||
| Short-term investments | 50,456 | 60,173 | ||
| Accounts receivable and unbilled receivable | 254 | 526 | ||
| Prepaid expenses and other current assets | 956 | 2,213 | ||
| Total current assets | 61,801 | 73,696 | ||
| Property and equipment, net | 666 | 743 | ||
| Operating lease right-of-use assets | 764 | 899 | ||
| Other assets | 549 | 401 | ||
| Total assets | 63,780 | 75,739 | ||
| Accounts payable | 2,441 | 6,010 | ||
| Accrued liabilities | 11,539 | 9,938 | ||
| Operating lease liabilities | 726 | 721 | ||
| Total current liabilities | 14,706 | 16,669 | ||
| Operating lease liabilities, net of current portion | 284 | 464 | ||
| Total liabilities | 14,990 | 17,133 | ||
| Common stock, 0.0001 par value, 150,000 shares authorized 67,095 and 66,524 shares issued and outstanding at september 30, 2025 and december 31, 2024 respectively | 7 | 7 | ||
| Additional paid-in capital | 471,547 | 470,138 | ||
| Accumulated other comprehensive gain | 50 | 17 | ||
| Accumulated deficit | -422,814 | -411,556 | ||
| Total stockholders equity | 48,790 | 58,606 | ||
| Total liabilities and stockholders equity | 63,780 | 75,739 | ||
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)